Literature DB >> 15237089

Myeloperoxidase and plaque vulnerability.

Stanley L Hazen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15237089     DOI: 10.1161/01.ATV.0000135267.82813.52

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  22 in total

Review 1.  Oxidized low-density lipoprotein biomarkers in atherosclerosis.

Authors:  Sotirios Tsimikas
Journal:  Curr Atheroscler Rep       Date:  2006-01       Impact factor: 5.113

2.  Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice.

Authors:  Peter J Gough; Ivan G Gomez; Paul T Wille; Elaine W Raines
Journal:  J Clin Invest       Date:  2005-12-22       Impact factor: 14.808

Review 3.  Molecular imaging in cardiovascular disease: targets and opportunities.

Authors:  Stanley Y Shaw
Journal:  Nat Rev Cardiol       Date:  2009-07-21       Impact factor: 32.419

4.  Protein carbamylation predicts mortality in ESRD.

Authors:  Robert A Koeth; Kamyar Kalantar-Zadeh; Zeneng Wang; Xiaoming Fu; W H Wilson Tang; Stanley L Hazen
Journal:  J Am Soc Nephrol       Date:  2013-02-21       Impact factor: 10.121

Review 5.  Polymorphonuclear neutrophils and instability of the atherosclerotic plaque: a causative role?

Authors:  Roberta Della Bona; Maria Teresa Cardillo; Milena Leo; Gina Biasillo; Massimo Gustapane; Francesco Trotta; Luigi M Biasucci
Journal:  Inflamm Res       Date:  2013-04-03       Impact factor: 4.575

6.  Lack of association between plasma myeloperoxidase levels and angiographic severity of coronary artery disease in patients with acute coronary syndrome.

Authors:  Eraldo de Azevedo Lucio; Sandro C Gonçalves; Jorge P Ribeiro; Gilberto L Nunes; Jarbas R de Oliveira; Gustavo N Araujo; Marco V Wainstein
Journal:  Inflamm Res       Date:  2010-09-17       Impact factor: 4.575

7.  Atherosclerosis Risk in Communities (ARIC) Carotid MRI flow cytometry study of monocyte and platelet markers: intraindividual variability and reliability.

Authors:  Diane J Catellier; Nena Aleksic; Aaron R Folsom; Eric Boerwinkle
Journal:  Clin Chem       Date:  2008-05-29       Impact factor: 8.327

8.  Rosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation--a novel mechanism for the cardioprotective effects of PPAR agonists.

Authors:  Hui-Rong Liu; Ling Tao; Erhe Gao; Yan Qu; Wayne Bond Lau; Bernard L Lopez; Theodore A Christopher; Walter Koch; Tian-Li Yue; Xin-Liang Ma
Journal:  Cardiovasc Res       Date:  2008-11-14       Impact factor: 10.787

9.  Identification of Critical Paraoxonase 1 Residues Involved in High Density Lipoprotein Interaction.

Authors:  Xiaodong Gu; Ying Huang; Bruce S Levison; Gary Gerstenecker; Anthony J DiDonato; Leah B Hazen; Joonsue Lee; Valentin Gogonea; Joseph A DiDonato; Stanley L Hazen
Journal:  J Biol Chem       Date:  2015-11-13       Impact factor: 5.157

10.  Monocytes and neutrophils expressing myeloperoxidase occur in fibrous caps and thrombi in unstable coronary plaques.

Authors:  Fabio R Tavora; Mary Ripple; Ling Li; Allen P Burke
Journal:  BMC Cardiovasc Disord       Date:  2009-06-23       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.